Hemotological Mechanisms underlying the Postoperative Analgesia-promoting effect of Dexmedetomidine on Opioids

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800015869

Enrollment

Unknown

Registered

2018-04-25

Start date

2018-05-10

Completion date

Unknown

Last updated

2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdonial hysteretomy

Interventions

general anesthesia group:general anesthesia

general anesthesia+dexmedetomidine group:intraoperative use of dexmedetomidine under general anesthesia

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ASA I-II grade, age 18-65, BMI<30, patients scheduled for abdominal hysterectomy.

Exclusion criteria

Exclusion criteria: smoking and alcohol abuse, opioids abuse or related history, postoperative nausea or vomiting history, chronic pain, neuropsychological disorders or related history, communication disability.

Design outcomes

Primary

Measure	Time frame
visal analouge scale;	—

Countries

China

Contacts

Public ContactDong-Jian Ge

The Huai'an First People's Hospital

44282385@qq.com+86 13852397912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026